| Literature DB >> 29400262 |
Wasif Raza1, Bertil Forsberg1, Christer Johansson2,3, Johan Nilsson Sommar1.
Abstract
BACKGROUND: Promotion of active commuting provides substantial health and environmental benefits by influencing air pollution, physical activity, accidents, and noise. However, studies evaluating intervention and policies on a mode shift from motorized transport to cycling have estimated health impacts with varying validity and precision.Entities:
Keywords: Active commuting; commuters’ exposure; comparative risk assessment; emission factors; exposure response function; mode shift; population exposure
Mesh:
Substances:
Year: 2018 PMID: 29400262 PMCID: PMC5804679 DOI: 10.1080/16549716.2018.1429081
Source DB: PubMed Journal: Glob Health Action ISSN: 1654-9880 Impact factor: 2.640
Figure 1.Flowchart of studies included in the review.
Air pollution impact calculation methods for the general population among, (a) the studies that only calculated air pollution effects among general population and (b) the studies that calculated air pollution effects among both general population and active commuters.
| Author (year) | Exposure Assessment | Pollutants | Ageᴬ | Exposure-response unction/Cost estimates |
|---|---|---|---|---|
| (a) | ||||
| Woodcock et al. 2009 [ | EM and DM Emission factors* | PM2.5 | All ages | Mortality: lung cancer and CR [ |
| Lindsay et al. 2010 [ | EM and DM Emission factors* | GHGE | Adultsᴮ | HAPINZᴱ [ |
| Grabow et al. 2012 [ | EM and DM Emission factors* | PM2.5 and O3 | All ages | BenMAPC [ |
| Dhondt et al. 2013 [ | EM and DM Emission factors* | EC | Adultsᴮ | All-cause mortality: Janssen et al. [ |
| Maizlish et al. 2013 [ | EM and DM Emission factors* | PM2.5 | All agesD | Mortality: CP [ |
| Woodcock et al. 2013 [ | Published estimates and Emission factors** | PM2.5 | All ages | Mortality: lung cancer and CR [ |
| Macmillan et al. 2014 [ | EM Emission factors* | PM10 and CO | Adultsᴮ | HAPINZᴱ [ |
| Xia et al. 2015 [ | EM with emission factors** | PM2.5 | All ages | RR from the literatureᴳ |
| Johansson et al. 2017 [ | Emission factors* and DM | NOx, NO2, and BC | 20–65 | Mortality: NOx: Nafstad et al. [ |
| (b) | ||||
| De Hartog et al. 2010H [ | DM | NO2 | AdultsD | All-cause mortality [ |
| Rabl et al. 2012 [ | EM with emission factors** | PM2.5 | All agesD | ExternEI [ |
| Rojas-Rueda et al. 2012H [ | DM Used the ratio of (PM2.5/PM10) | PM2.5 | All ages | All-cause mortality [ |
| Rojas-Rueda et al. 2013H [ | DM Used the ratio of (PM2.5/PM10) | PM2.5 | All agesD | RR for morbidity from the literatureJ |
| Buekers et al. 2015 [ | Proportion of transport emission | PM 2.5 | All agesD | All-cause mortality [ |
EM: emission model (for initial prediction of traffic emission); DM: (dispersion model to calculate change in pollutants concentration); GHGE: greenhouse gas emission; EC: elemental carbon; PM2.5: Particulate matter less than 2.5 µm; PM10: particulate matter less than 10 µm; CO: carbon monoxide; O3: ozone; NO2: nitrogen dioxide; CVD: cardiovascular disease, CP: cardiopulmonary; CR: cardiorespiratory; ARI: acute respiratory infection; RI: respiratory infection; RM: respiratory mortality. *Published emission factors but not reported in text. **Emission factors reported explicitly in text ᴬ Age groups according to health outcomes; ᴯ Such as ≥18 years or ≥30 years; C Environmental Benefits Mapping and Analysis Program using the concentration response function from chronic bronchitis [63], acute bronchitis [64], all-cause mortality [65,104], COPD hospitalization (Moolgavgkar 2000a, 2003) [66], asthma emergency room visits [67], work loss days [68], asthma (symptoms) [69], minor-restricted activity days [70], acute MI [71], respiratory disease [72], lower respiratory symptoms [73], and cough among asthmatic children [74]; D Probable, but not specified explicitly in the text; ᴱ Health And Air Pollution Study in New Zealand to estimate the morbidity and mortality health costs associated with traffic emissions [82]; FCVD admission >64 years: [75]; ᴳ Mortality: <75 and >75 years, respiratory disease (65 years) [76], and lung cancer [104] Morbidity: CVD, respiratory disease [76], and lung cancer [104]; H Method of transport emission estimation is quite vague in determination of emission factors; I External cost of energy to estimate the automotive pollution impact on health in Europe [81]; J Cerebrovascular disease and lower respiratory tract infection [77], preterm weight [78], low term weight [79], and CVD (Mustafic 2012) [80]; K Value of a Life Year: calculation of monetary benefits of mortality reduction using a life tables approach.
Air pollution impact calculation methods for commuters among, (a) the studies that only calculated air pollution effects among active commuters and (b) the studies that calculated air pollution effects among both general population and active commuters.
| Author (year) | Actual/Estimated | Age (years)ᴬ | Exposure Assessment | Pollutants | Dose | Exposure response function |
|---|---|---|---|---|---|---|
| (a) | ||||||
| Rojas- Rueda et al. 2011 [ | ActualE | 16–64 | Mode- specific concentration | PM2.5 | Mode- specific concentration, inhalation rate, and trip duration. | All-cause mortality: Krewski et al. [ |
| Holm et al. 2012 [ | EstimatedF | AdultsC | Average from two street monitoring sites | PM2.5 | Average from two street monitoring sites, inhalation rate, and trip duration | Mortality: CP and lung cancer [ |
| Woodcock et al. 2014 [ | ActualE | ≥15 | Based on mode-specific scaling factors | PM2.5 | Mode-specific concentration, inhalation rate, and trip duration | Mortality: CP and lung cancer (>30 years): Pope et al. [ |
| Rojas-Rueda et al. 2016 [ | EstimatedF | 16–64 | Mode- specific concentration | PM2.5 | Mode- specific concentration, inhalation rate, and trip duration | All-cause mortality [ |
| (b) | ||||||
| De Hartog et al. 2010 [ | EstimatedF | Adultsᴯ | Mode- specific concentration | PM2.5, BS | Mode specific concentration, inhalation rate, and trip duration | All-cause mortality:PM2.5 [ |
| Rabl et al. 2012 [ | EstimatedF | 20–65 | Based on mode- specific scaling factors | PM2.5 | Mode- specific concentration, inhalation rate, and trip duration | ExternED [ |
| Rojas-Rueda et al. 2012 [ | EstimatedF | 16–64 | Mode- specific concentration | PM2.5 from PM10 | Mode- specific concentration, inhalation rate, and trip duration | All-cause mortality [ |
| Rojas-Rueda et al. 2013 [ | EstimatedF | 16–64 | Mode- specific concentration | PM2.5 | Mode- specific concentration, inhalation rate, and trip duration | RR for morbidity from the literatureG |
| Buekers et al. 2015 [ | ActualE | AdultsC | Mode specific concentration | PM2.5 | Mode- specific concentration, inhalation rate, and trip duration | All-cause mortality (WHO; 2013) [ |
PM2.5: Particulate matter less than 2.5 µm; PM10: particulate matter less than 10 µm; BS: black soot; CP: cardiopulmonary; RM: respiratory mortality. ᴬ Age groups according to health outcomes; ᴯ Such as ≥18 years or ≥30 years; C Probable, but not specified explicitly in the text; D External cost of energy to estimate the automotive pollution impact on health in Europe [81]; E Calculation based on the actual number of participants who changed mode from car to bicycle; F Estimated for hypothetical individuals who changed transport mode from car to bicycle; G Cerebrovascular disease and lower respiratory tract infection [77], preterm weight [78], low term weight [79], and CVD (Mustafic 2012) [80]; H Value of a Life Year: calculation of monetary benefits of mortality reduction using a life tables approach.